RE:This either needs to help get us on the Nasdaq I did just read that Therapix is PhaseII of a clinical trial for tourettes (sp) syndrome at Yale University. This sounds good. They have a few other trials for other illnesses with other Universities which I am pleased to read. The valuation just seems high to pay so I can only imagine this will propel us onto the Nasdaq.
PJStocks wrote:
or get us some sort of patented pain management system or cure/formula to help with another big disease. Otherwise the deal doesn't make sense IMO so I hope that what's were getting with this. It's the only thing that makes any sense.